Stay updated on Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.3.2 is now displayed, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe government funding status notice banner was removed from the page.SummaryDifference0.4%

- Check43 days agoChange DetectedThe screenshots show no significant changes to core study information such as inclusion criteria, primary outcomes, endpoints, or locations; observed differences are limited to formatting and user interface elements. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check72 days agoChange DetectedMajor update: new operating-status notice and a version upgrade to v3.2.0, replacing v3.1.0.SummaryDifference2%

- Check79 days agoChange DetectedPage version updated from v3.0.2 to v3.1.0 with added contact/identifier strings; no clear changes to core content, pricing, or availability.SummaryDifference0.0%

- Check93 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' link. No changes to core content, pricing, stock, or time slots.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page.